Literature DB >> 22144095

Tim-1 regulates Th2 responses in an airway hypersensitivity model.

Miranda L Curtiss1, Jacob V Gorman, Thomas R Businga, Geri Traver, Melody Singh, David K Meyerholz, Joel N Kline, Andrew J Murphy, David M Valenzuela, John D Colgan, Paul B Rothman, Suzanne L Cassel.   

Abstract

T-cell immunoglobulin mucin-1 (Tim-1) is a transmembrane protein postulated to be a key regulator of Th2-type immune responses. This hypothesis is based in part upon genetic studies associating Tim-1 polymorphisms in mice with a bias toward airway hyperrespon-siveness (AHR) and the development of Th2-type CD4(+) T cells. Tim-1 expressed by Th2 CD4(+) T cells has been proposed to function as a co-stimulatory molecule. Tim-1 is also expressed by B cells, macrophages, and dendritic cells, but its role in responses by these cell types has not been firmly established. Here, we generated Tim-1-deficient mice to determine the role of Tim-1 in a murine model of allergic airway disease that depends on the development and function of Th2 effector cells and results in the generation of AHR. We found antigen-driven recruitment of inflammatory cells into airways is increased in Tim-1-deficient mice relative to WT mice. In addition, we observed increased antigen-specific cytokine production by splenocytes from antigen-sensitized Tim-1-deficient mice relative to those from controls. These data support the conclusion that Tim-1 functions in pathways that suppress recruitment of inflammatory cells into the airways and the generation or activity of CD4(+) T cells.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22144095      PMCID: PMC3528103          DOI: 10.1002/eji.201141581

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  35 in total

1.  T cell Ig and mucin 1 (TIM-1) is expressed on in vivo-activated T cells and provides a costimulatory signal for T cell activation.

Authors:  Anjali J de Souza; Timothy B Oriss; Katherine J O'malley; Anuradha Ray; Lawrence P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

2.  TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation.

Authors:  Jennifer Hartt Meyers; Sumone Chakravarti; David Schlesinger; Zsolt Illes; Hanspeter Waldner; Sarah E Umetsu; James Kenny; Xin Xiao Zheng; Dale T Umetsu; Rosemarie H DeKruyff; Terry B Strom; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

3.  TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.

Authors:  Sarah E Umetsu; Wan-Ling Lee; Jennifer J McIntire; Laura Downey; Bharati Sanjanwala; Omid Akbari; Gerald J Berry; Haruo Nagumo; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

4.  Surveillance for asthma--United States, 1960-1995.

Authors:  D M Mannino; D M Homa; C A Pertowski; A Ashizawa; L L Nixon; C A Johnson; L B Ball; E Jack; D S Kang
Journal:  MMWR CDC Surveill Summ       Date:  1998-04-24

Review 5.  Novel roles for TIM-1 in immunity and infection.

Authors:  Paul D Rennert
Journal:  Immunol Lett       Date:  2011-09-02       Impact factor: 3.685

6.  Evidence for natural selection in the HAVCR1 gene: high degree of amino-acid variability in the mucin domain of human HAVCR1 protein.

Authors:  T Nakajima; S Wooding; Y Satta; N Jinnai; S Goto; I Hayasaka; N Saitou; J Guan-Jun; K Tokunaga; L B Jorde; M Emi; I Inoue
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

7.  Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma.

Authors:  Jeffrey A Encinas; Edith M Janssen; David B Weiner; Sandra A Calarota; Daisy Nieto; Thomas Moll; Dennis J Carlo; Ronald B Moss
Journal:  J Allergy Clin Immunol       Date:  2005-10-03       Impact factor: 10.793

8.  Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation.

Authors:  Dominique Davidson; Xiaochu Shi; Shaohua Zhang; Hao Wang; Mona Nemer; Nobuyuki Ono; Shinji Ohno; Yusuke Yanagi; André Veillette
Journal:  Immunity       Date:  2004-11       Impact factor: 31.745

9.  SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1.

Authors:  Jennifer L Cannons; Li J Yu; Brenna Hill; Lilia A Mijares; Derek Dombroski; Kim E Nichols; Anthony Antonellis; Gary A Koretzky; Kevin Gardner; Pamela L Schwartzberg
Journal:  Immunity       Date:  2004-11       Impact factor: 31.745

10.  Risk factors for near-fatal asthma.

Authors:  Arthur F Gelb; Aaron Schein; Eliezer Nussbaum; Chris M Shinar; Yossef Aelony; Haig Aharonian; Noe Zamel
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

View more
  14 in total

1.  Protective association of TIM1-1454G>a polymorphism with asthma in a North Indian population.

Authors:  Shweta Sinha; Jagtar Singh; Surinder Kumar Jindal
Journal:  Lung       Date:  2014-10-21       Impact factor: 2.584

2.  Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.

Authors:  Amanda C Foks; Daniel Engelbertsen; Felicia Kuperwaser; Noah Alberts-Grill; Ayelet Gonen; Joseph L Witztum; James Lederer; Petr Jarolim; Rosemarie H DeKruyff; Gordon J Freeman; Andrew H Lichtman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-28       Impact factor: 8.311

Review 3.  Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Authors:  A C Foks; J Kuiper
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

4.  Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma.

Authors:  Weiqing Jing; Jill A Gershan; James Weber; Dominique Tlomak; Laura McOlash; Catherine Sabatos-Peyton; Bryon D Johnson
Journal:  J Immunother Cancer       Date:  2015-01-20       Impact factor: 13.751

Review 5.  Immune Regulation and Antitumor Effect of TIM-1.

Authors:  Peng Du; Ruihua Xiong; Xiaodong Li; Jingting Jiang
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

6.  Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy.

Authors:  Qing-Hui Zhang; Rui-Xing Yin; Wu-Xian Chen; Xiao-Li Cao; Yu-Ming Chen
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

7.  Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.

Authors:  Patrick Younan; Mathieu Iampietro; Andrew Nishida; Palaniappan Ramanathan; Rodrigo I Santos; Mukta Dutta; Ndongala Michel Lubaki; Richard A Koup; Michael G Katze; Alexander Bukreyev
Journal:  mBio       Date:  2017-09-26       Impact factor: 7.867

8.  IFNAR2-dependent gene expression profile induced by IFN-α in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection.

Authors:  Qian Zhang; Lei-Ping Zeng; Peng Zhou; Aaron T Irving; Shang Li; Zheng-Li Shi; Lin-Fa Wang
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

9.  Immune Cell Repertoire and Their Mediators in Patients with Acute Myocardial Infarction or Stable Angina Pectoris.

Authors:  Wenwen Yan; Yanli Song; Lin Zhou; Jinfa Jiang; Fang Yang; Qianglin Duan; Lin Che; Yuqin Shen; Haoming Song; Lemin Wang
Journal:  Int J Med Sci       Date:  2017-02-08       Impact factor: 3.738

10.  Murine Tim-1 is excluded from the immunological synapse.

Authors:  Jean Lin; Leo Chen; Lawrence P Kane
Journal:  F1000Res       Date:  2012-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.